Results 91 to 100 of about 2,223 (166)

Elemental Impurities in Gelatine Capsules: Human Health Risk Assessment

Безопасность и риск фармакотерапии
INTRODUCTION. This work continues the authors’ earlier study on gelatine capsule contamination with elemental impurities, which resulted in proposing a list of elements for standardisation. To ensure the safe use of medicinal products in this dosage form,
V. M. Schukin, N. E. Kuz'mina, O. A. Matveeva, Yu. N. Shvetsova, E. S. Zhigilei   +4 more
doaj   +1 more source

Individual Differences in Growth and in Accumulation of Secondary Metabolites in Rhodiola rosea Cultivated in Western Siberia. [PDF]

Int J Mol Sci, 2023
Erst AA, Kotsupiy OV, Erst AS, Kuznetsov AA.   +3 more
europepmc   +1 more source

Validation of the method for determination of prekallikrein activator in Human Albumin

Биопрепараты: Профилактика, диагностика, лечение, 2018
Prekallikrein activator (PKA) is regarded as one of the most important factors determining the safety of blood products such as albumin and intravenous immunoglobulin.
M. V. Tomilin, E. V. Filatova, M. M. Kuznetsova, V. V. Sudakova, N. V. Zubkova   +4 more
doaj  

Modification of the Physicochemical Properties of Active Pharmaceutical Ingredients via Lyophilization. [PDF]

Pharmaceutics, 2023
Taldaev A, Pankov DI, Terekhov RP, Zhevlakova AK, Selivanova IA.   +4 more
europepmc   +1 more source

GENERAL MONOGRAPHS ON PROBIOTICS PREPARATIONS FOR STATE PHARMACOPOEIA OF THE RUSSIAN FEDERATION XIII EDITION – FIRST EXPERIENCE IN THE WORLD PHARMACOPOEIA PRACTICE [PDF]

International Journal of Applied and Fundamental Research (Международный журнал прикладных и фундаментальных исследований), 2016
openaire   +1 more source

Automated Optimized Synthesis of [¹⁸F]FLT Using Non-Basic Phase-Transfer Catalyst with Reduced Precursor Amount. [PDF]

Molecules, 2022
Fedorova OS, Orlovskaya VV, Krasikova RN.   +2 more
europepmc   +1 more source

Challenges Associated with Forming Generic Names for Herbal Medicinal Products

Регуляторные исследования и экспертиза лекарственных средств
INTRODUCTION. The lack of a unified approach to establishing generic (grouping) names, which must be specified for herbal medicinal products, presents a challenge to developers and manufacturers preparing registration dossiers, as well as to regulators ...
L. N. Frolova, E. L. Kovaleva, V. V. Shelestova, V. Yu. Kuteynikov, N. G. Olenina   +4 more
doaj   +1 more source

Soviet pharmaceutical regulation (1918-1990). [PDF]

CMAJ, 2021
Vasilyev P, Petrenko A, Tayukina V.
europepmc   +1 more source

Spray Film-Forming systems as promising topical in situ Systems: A review. [PDF]

Saudi Pharm J, 2023
Bakhrushina EO, Shumkova MM, Sergienko FS, Novozhilova EV, Demina NB.   +4 more
europepmc   +1 more source

Current and Future Pharmacopoeial Requirements for the Quality of Extemporaneous Medicinal Products: A Review of Regulatory Standards

Регуляторные исследования и экспертиза лекарственных средств
INTRODUCTION. The organisation of extemporaneous compounding in pharmacies is currently considered to be a priority for the national healthcare system.
L. I. Shishova, A. V. Yarutkin, V. L. Bagirova   +2 more
doaj   +1 more source